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INTRODUCTION
Many non-invasive and invasive parameters have
been proposed and tested to identify patients at risk for
sudden cardiac death (SCD) (1, 2). More recently, the
availability of implantable cardioverter defibrillator (ICD)
has made patients’ selection an even more relevant is-
sue (3-6). Low left ventricular ejection fraction (7), fre-
quent ventricular ectopic beats (7), fast mean heart rate
(8), low heart rate variability (HRV) (9, 10), reduced baro-
reflex sensitivity (11), non-sustained ventricular tachy-
cardia (NSVT) (5) and induction of ventricular tachycar-
dia at electrophysiological study (5) were considered
markers of either reduced cardiac function, increased
electrical instability or abnormal autonomic control me-
chanisms. Nevertheless, when these parameters have
been used in prospective studies, the results were often
unsatisfactory if not controversial (1, 2).
It is also plausible that risk assessment, performed at
the time of discharge after an index event or at the time
of study inclusion, could maintain its value only for a li-
mited time as a consequence of disease progression
and substrate change. The possibility that  before a life
threatening arrhythmic event, additional changes in the
electrical substrate and autonomic control mechanisms
might occur, has therefore to be taken into considera-
tion in the process of risk stratification (12). 
Heart Rate Turbulence (HRT) is a recently described
(13) method to assess arrhythmic risk in post-myocar-
dial infarction patients based on the evaluation of ven-
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ABSTRACT: Background: To evaluate the changes in autonomic neural control mechanisms be-
fore  malignant ventricular arrhythmias, we measured heart rate variability (HRV) and heart rate
turbulence (HRT) in patients with ventricular tachycardia or fibrillation (Group I; n=6), non sus-
tained ventricular tachycardia (Group II; n=32), frequent premature ventricular beats (Group III;
n=26) and  with ICD implantation (Group IV; n=11).
Methods: Time domain parameters of HRV and turbulence onset (TO) and slope (TS) were cal-
culated on 24 hour Holter recordings. Normal values were:  SDNN > 70 msec for HRV, TO <0%
and TS >2.5 msec/RR-I for HRT.
Results: Whereas SDNN was within normal range and similar in all study groups, HRT parame-
ters were significantly different in patients who experienced VT/VF during Holter recording. Ab-
normal TO and/or TS were present  in 100% of  Group I patients and only in about 50% of Group
II and IV. On the contrary, normal HRT parameters were present in 40-70% of Group II, III and IV
patients and none of Group I.
Conclusions: These data suggest that HRT analysis is more suitable than HRV to detect those
transient alterations in autonomic control mechanisms that are likely to play a major trigger role
in the genesis of malignant cardiac arrhythmias. (Heart International 2007; 3: 51-7)
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triculophasic sinus arrhythmia following premature ven-
tricular beats (PVBs). HRT has been found effective in
identifying  SCD  victims in post-AMI patients according
to retrospective (13, 14) and, more recently, prospective
studies (15). Aim of our study was to analyse HRV and
HRT in the hours preceding ventricular tachycardia or fi-
brillation in patients exhibiting these arrhythmias during
Holter recordings. 
SUBJECTS AND METHODS
Patient population
The study is based on the analysis of Holter record-
ings of 64 patients referred to our Institution in the pe-
riod 2003-2005. The reference group was made by 6
outpatients who experienced sustained ventricular
tachycardia or ventricular fibrillation during the 24
hour recording performed for evaluation of palpitations
(Group I). Two of these patients died during the Holter
recording  for  ventricular fibrillation. Thirty-two pa-
tients who presented NSVT during a Holter recording
were also included (Group II). Twenty-six consecutive
patients with frequent premature ventricular beats
(PVBs), > 10/h, were included in Group III. A fourth
group of  11 patients with an implanted cardioverter
defibrillator (ICD), but not sustained ventricular ar-
rhythmias during the index Holter recording were also
considered. None of the patients presented atrial fibril-
lation, permanent pacemaker rhythm or artefacts that
could affect sinus rhythm fluctuation analysis during
the Holter recording. 
Complete clinical data were only available for ICD pa-
tients and survivors of VT. Demographic data of  all the
patients are presented in Table I.
The study was approved by the Ethical Committee of
our institution.
HRV analysis  
After visual inspection and manual editing of the 24
hour recording, standard deviation of normal RR inter-
vals (SDNN) was automatically computed with the
Synetec software (ver. 1.20, Ela Medical, France). In all
groups the duration of recording was greater than 18
hours and included a nocturnal period.
HRT analysis  
Turbulence Onset (TO) was calculated as the percent-
age change between the mean of the first 2 sinus RR in-
tervals after a PVB and the last 2 sinus RR intervals before
the PVB, as follows: TO=[(RR1 - RR2)-(RR-2 - RR-1)]/(RR-2 -
RR-1), where RR1 is the i-th sinus rhythm following (i>0)
the compensatory pause of the PVB or preceding (i<0) the
coupling interval of the PVB. These measurements were
performed for each singular PVB and subsequently aver-
aged. Turbulence Slope (TS) was calculated as the maxi-
mum positive slope of a regression line assessed over any
sequence of 5 subsequent RR intervals within the
tachogram RR1, RR2, RR3, . . . , RR15, where RRi is the av-
erage of i-th sinus rhythm RR intervals after the compen-
satory pause of a singular PVB (HRT source code 1.1 is
available on http://www.h-r-t.org).
TO and TS were dichotomized at predefined cut
points (TO ≥ 0% and < 0%, TS < 2.5 and ≥ 2.5 ms per
normal-to-normal interval) (13).
Statistical analysis
Continuous data are presented as mean ± SD. Cate-
gorical data as number of patients (percentage). PVB
number is logarithmic transformed. Significant differen-
ces for continuous variables were tested with analysis
of variance (ANOVA); Chi-square or Exact Fisher test
when appropriate for categorical variables. Post-hoc
Bonferroni test was performed after ANOVA to test indi-
vidual differences. Pearson’s coefficients were calcula-
ted to correlate HRV and HRT parameters. A significant
two-tailed p level of 0.05 was considered. All statistical
analysis were performed with the commercial software
SPSS (Release 13.0, SPSS inc., USA). 
RESULTS
Clinical characteristics of patients enrolled in the
study are presented in Table I. Age and gender did not
differ among the four groups. Only a significant lower
number of PVBs was present in ICD patients.
Mean heart rate and SDNN were similar in the four
groups. Of interest was the finding  that all mean values of 24
hour  SDNN were above 70 msec; the cut-off value used in
our laboratory to identify high risk post-MI patients (Fig. 1). Lombardi et al
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On the contrary, we observed a significant difference
of HRT parameters in patients who presented VT or VF
during Holter recordings (Group I) in comparison to
Group II and III patients (Figs. 2 and 3; Tab. II). When
considering data as categorical variables, the difference
was more evident : TS value < 2.5 msec/RR interval was
detectable in all Group I subjects and only in 34% and
27% of, respectively, Group II and III patients. A TO ≥
0% was present in 67% of VT/VF patients and in 41%
and 15% of, respectively, NSVT (Group II)  and frequent
PVB (Group III) patients. 
In ICD patients, abnormal TO and TS values were ob-
served in 36% and 45% of cases; these percentages
were significantly different from that of Group I (VT/VF)
but similar to patients with NSVT (Tab. III). 
TS, as previously reported (11-13), appeared more sen-
sitive in revealing differences among groups when consid-
ered either as a continuous or categorical variable (Fig. 4)
Fig. 1 - Mean values of 24 hour SDNN in patients with VT/VF
(group I), non sustained ventricular tachycardia (Group II), frequent
premature ventricular beats (Group III) and ICD (Group IV).
Fig. 2 - Comparison of TO absolute values in the four study groups.
A significant difference between Group I and III was evident.
Fig. 3 - Comparison of TS absolute values in the four study groups.
A significant difference between Group I and III was evident.
Fig. 4 - Distribution of normal and abnormal HRT parameters in the
different study groups according to cut-off values of <0% for TO
and >2.5 msec/RR-I for TS. At least one abnormal parameter (5th
set of data) was present in all VT/VF patients, whereas in only
about 50% of ICD or NSVT patients. Normal HRT parameters were
present (3rd set of data) in none of VT/VF patients but in about 40-
70% of Group II, III and IV patients.HRT and ventricular fibrillation
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When we correlated HRV and HRT parameters of all
study group, a modest but significant correlation be-
tween SDNN and TO (r=-0.38; p=0.003) or TS (r=0.41;
p=0.001) was detectable (Fig. 5).
DISCUSSION
In this study, we reported that HRT was superior to
HRV to reflect those alterations in autonomic control of
sinus node beforeVT or VF episodes during Holter re-
cordings. This was evident when considering HRT para-
meters either as continuous or, more consistently, as
categorical variable. On the contrary,  patients with ICD
(Group IV), i.e. with history of previous cardiac arrest or
sustained VT but no sustained ventricular arrhythmias in
the index Holter recording, presented values of HRT si-
milar to patients with NSVT or frequent ectopic beats. 
Fig. 5 - Linear correlation between TS and SDNN in all study pop-
ulation.
TABLE I - CLINICAL CHARACTERISTICS OF THE STUDY POPULATION
Group I (n=6) Group II (n=32) Group III (n=26) Group IV (n=11) p value
Age (years) 72 ± 6 66.8 ± 11 65.5 ± 14 70 ± 7 0.569
Gender (male) 5 (83.3%) 18 (56.3%) 15 (57.7%) 9 (81.8%) 0.572
Indications to 24 hour Holter recording:
Rhythm control 0 (0%)  5 (15.6%) 4 (15.4%) 0 (0%)
Palpitations 0 (0%) 0 (0%) 3 (11.5%) 0 (0%)
PVBs (%)  0 (0%) 3 (9.3%) 3 (11.5%) 0 (0%)
Cardiomyopathy 1 (16.6%) 4 (12.5%) 2 (7.7%) 0 (0%)
Syncope 1 (16.6%)  4 (12.5%) 5 (19.2%) 0 (0%)
ICD control 3 (50%) 0 (0%)  0 (0%) 10 (90.9%)
CAD 1 (16.6%) 6 (18.75%) 1 (3.8%) 1 (9.1%)
Unknown 0 (0%) 12 (37.5%) 8 (30.7%) 0 (0%)
Ln PVBs (number) 5.0 ± 1.5 5.4 ± 1.5 4.9 ± 1.3 3.2 ± 1.6 0.004
PVB= premature ventricular beats; ICD= implantable cardioverter defibrillator; CAD= coronary artery disease
TABLE II - HRV AND HRT PARAMETERS IN THE STUDY POPULATION
Group I (n=6) Group II (n=32) Group III (n=26) Group IV (n=11) p  value
SDNN (msec) 104 ± 43 106 ± 41 111 ± 38 111 ± 20 0.951
Mean RR interval (msec) 825 ± 156 833 ± 153 824 ± 137 904 ± 134 0.565
Turbulence onset (%) 0.04507 ± 0.011 -0.0058 ± 0.013 -0.0171 ± 0.015 -0.0068 ± 0.012 0.001
Turbulence slope (msec/RR-i) 1.624 ± 0.58 4.117 ± 3.18 5.607 ± 4.06 3.608 ± 3.12 0.053
SDNN= standard deviation of normal RR intervalsLombardi et al
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HRV and arrhythmic mortality
It’s well established HRV parameters may predict wor-
se prognosis with increased risk for cardiovascular and
overall mortality in many cardiovascular diseases (10).
Most of evidences came from studies investigating risk
for sudden cardiac death after an acute MI or in survivors
of cardiac arrest (10, 16-18). The association between
HRV reduction and prediction of arrhythmic mortality re-
mains, however, controversial as recent reports have fai-
led to demonstrate a distinct HRV pattern in relation to
the type of death (15, 19). In the ATRAMI study (20), for
example, HRV reduction was associated with increased
total but not arrhythmic mortality.  More recently, Huikuri
et al (19) also reported that HRV was more related to total
cardiac rather than arrhythmic mortality. Being the me-
chanisms of arrhythmic and non-arrhythmic cardiac mor-
tality quite different, the interpretation of HRV reduction
remains difficult from both a physiological and risk strati-
fication point of view (10, 21, 22). This issue is even more
controversial when considering heart failure patients (10,
23, 24). 
A reduction in time domain parameters of HRV in pa-
tients with cardiac arrest during Holter recordings was fir-
st reported by Martin et al (25). Subsequently, Huikuri et
al (26) and Valkama et al (27) observed a reduction of
SDNN in patients with a history of sustained ventricular
tachycardia in comparison to patients without repetitive
ventricular arrhythmias during Holter recordings. In the
present study carried out in ambulatory patients we
found, instead, a preserved HRV in all four groups, with
mean SDNN above the cut-off value of 70 msec. It must
be recalled that, in the literature, discordant results in
SDNN calculation were observed in relation to the dura-
tion of the observational period before arrhythmic event:
SDNN values were found to be reduced when calculated
in the 5-minutes interval immediately before arrhythmia
onset (28), whereas it was found unchanged, increased
or reduced when longer recordings were analysed (10,
26-28). Data from the analysis of ICD memory seems to
support this hypothesis. Indeed Pruvot et al (29) and
Lombardi et al (30) found consistent alterations of time
and frequency domain parameters of HRV only in the mi-
nutes preceding the detected arrhythmic event. A possi-
ble explanation of the above findings is that HRV para-
meters measured over a 24 hour period may reflect those
chronic alterations of autonomic control mechanisms
that may predispose ventricular arrhythmias rather than
unmasking sudden variations in autonomic modulation
that may play as a trigger for arrhythmias occurrence.
HRT and HRV analysis before VT/VF 
HRT was described for the first time in 1999 and vali-
dated on the data base of three large clinical trials
(13,14). More recently, the results of a large prospective
study have been published confirming the predictive va-
lue of HRT for risk stratification of post-MI patients (15).
In these studies, alteration of both TO and TS parameters
were associated with increased all-cause mortality. In the
ATRAMI study (15), TO and TS were the most important
independent risk predictors for cardiac mortality together
with LVEF. Moreover, when HRT was compared with other
accepted risk parameters like SDNN, baroreflex sensiti-
vity, presence of NSVT at Holter recording, only TS, i.e.
the most sensitive parameter of HRT, showed a signifi-
cant association with  increased mortality (15).
The results of our study confirm the greater sensiti-
TABLE III - DIFFERENT DISTRIBUTION OF NORMAL AND ABNORMAL HRT PARAMETERS IN THE STUDY POPULATION
Group I (n=6) Group II (n=32) Group III (n=26)   Group IV (n=11) P value
T Onset <0% 33% 59% 85% 64% 0.056
T slope >2.5 msec/RR-i 0% 66% 73% 55% <0.01
TO <0% and TS >2.5 ms/RR-I
(“normal”) 0% 50% 73% 40% <0.01
TO >0% and TS <2.5 ms/RR-I
(“abnormal”) 67% 25% 15% 30% 0.077
TO >0% or TS <2.5 ms/RR-I
(“one of two abnormal”) 100% 50% 27% 54% 0.01HRT and ventricular fibrillation
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vity of HRT parameters in comparison to SDNN in re-
flecting those alterations of autonomic control mechani-
sms that precede the onset of malignant ventricular
arrhythmias. Indeed more than 60% of patients with a
history of aborted SCD had normal HRV and HRT, whe-
reas all patients who experienced VT/VF during the Hol-
ter recording had an abnormal HRT. Of interest were the
findings that SDNN was >70 msec in 4 out of 6 Group I
patients and that the percentage of alteration of HRT
parameters in ICD patients (Group IV) was similar to that
of NSVT patients (Group II). All these findings seem the-
refore to confirm the capability of HRT to detect not only
those substrate alterations that may predispose to
arrhythmias but also those additional transient altera-
tions in autonomic control mechanisms likely to play a
major pro-arrhythmic role.
The underlying mechanisms advocated to explain
changes in HRV and HRT may partially explain our re-
sults. SDNN has been considered to reflect global auto-
nomic balance: its reduction is commonly interpreted as
an indirect evidence of a diminished vagal tone and an
increased sympathetic modulation of sinus node (10).
HRT, which is known to reflect ventriculophasic sinus
arrhythmia, is highly correlated with baroreflex sensiti-
vity. Consequently, abnormal HRT parameters more di-
rectly reflect a reduced vagal reflex efferent activity cau-
sed by impaired baroreflex mechanisms (31-33). In-
deed, it has been previously reported that HRT and, in
particular TS, is significantly correlated to baroreflex
sensitivity, whereas in the present as in previous re-
ports, the correlation  between HRT and HRV parame-
ters was less strong.
An additional point that may explain the greater sen-
sitivity of HRT in comparison to HRV is the effect of edi-
ting premature ventricular beats in HRV analysis: ventri-
cular ectopies are a prerequisite to compute HRT whe-
reas they represent a limitation requiring time-consu-
ming editing of data, interpolations of RR intervals and
possibility of distortion of the tachogram when HRV
computed. The clinical significance of this processing
has never been evaluated in HRV studies and could ha-
ve prevented a more appropriate evaluation of abnormal
autonomic control mechanisms in patients with cardiac
electrical instability.
Study limitations
There are few but important limitations in the present
study: First of all, population was quite small and hete-
rogeneous being based on outpatient clinic; second,
patients were distributed in the different groups accor-
ding to arrhythmias number and complexity rather than
on clinical characteristics. Third, complete clinical data
were not available being the study based on outpatient
records.
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